Overview

The science of psychedelic medicine has undergone a quiet revolution. In controlled clinical trials, MDMA-assisted therapy has produced remarkable results for PTSD. Psilocybin has shown unprecedented outcomes in treatment-resistant depression and end-of-life anxiety. Ketamine is already FDA-approved. A federal executive order has directed the acceleration of psychedelic medicine research. Mind Unlocked is a rigorous, science-first guide to the psychedelic medicine revolution - what the research actually shows, how these medicines work in the brain, who they help, and what the emerging clinical landscape looks like. Inside, you'll find: - The neuroscience of psychedelics: how psilocybin, MDMA, ketamine, and DMT interact with serotonin receptors and the default mode network - The clinical evidence: what Phase 2 and Phase 3 trials show for PTSD, depression, addiction, and end-of-life anxiety - How MAPS, Johns Hopkins, NYU, and Imperial College London are conducting trials - The legal landscape: what's FDA-approved, what's in trials, and what's in legal therapeutic programs - The history: how a 50-year government ban froze a promising field of medicine - and how it thawed - The risks: who shouldn't use these medicines and what the adverse event data shows Not advocacy. Not hype. Science.

Full Product Details

9798259481596

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available